Which body adds GLP1s to essential medicines list

WHO Updates Essential Medicines List with New Cancer and Diabetes Treatments

The World Health Organization (WHO) has released its updated Model List of Essential Medicines (EML) and Essential Medicines for Children (EMLc), incorporating crucial new treatments for various health challenges.

Focus on Cancer Treatments

The updated lists now include innovative therapies for several types of cancer, offering new hope for patients worldwide. These additions aim to improve access to effective cancer care, particularly in resource-limited settings.

Addressing Diabetes and Obesity

Recognizing the growing global burden of diabetes and obesity, the WHO has also added new medications to manage these conditions and related complications. This expansion reflects the importance of comprehensive care for metabolic disorders.

Key Highlights of the Updated List:

• Inclusion of new cancer treatments for improved patient outcomes.
• Addition of medicines for diabetes and obesity management.
• Emphasis on ensuring access to essential medicines globally.

Importance of Essential Medicines Lists

The WHO’s EML and EMLc serve as a guide for countries in developing their own national lists of essential medicines. These lists help prioritize the procurement and distribution of the most effective and safe medicines for a population’s most pressing health needs.

Final Overview

The latest updates to the WHO’s Essential Medicines List represent a significant step forward in global healthcare. By including new treatments for cancer, diabetes, and obesity, the WHO is working to ensure that people around the world have access to the medicines they need to live healthier lives. These changes will guide healthcare policy and improve access to vital medications worldwide.